Abstract
Transcatheter arterial chemoembolization (TACE) is the interventional technique and mainstay of treatment for unresectable hepatocellular carcinoma (HCC). TACE is indicated mainly for unresectable HCC, cholangiocarcinoma, and hepatic metastases. In this method if used worldwide; however, many regimens, embolic materials, and techniques exist. The clinical results are also controversial. We present the history and the status of TACE for HCC.
Keywords: HCC, History, Interventional radiology, Lipiodol, TACE.
About this chapter
Cite this chapter as:
Naoyuki Toyota, Takuji Yamagami, Noriaki Matsuura, Naoko Akiyama, Hiromi Miyoshi, Takahiro Sueoka, Kazuo Awai ;Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Does TACE Have a Future?, Advances in Modern Medicine (2017) 1: 99. https://doi.org/10.2174/9781681080239117010014
DOI https://doi.org/10.2174/9781681080239117010014 |
Publisher Name Bentham Science Publisher |